Women with a rare type of ovarian cancer have prolonged survival after receiving immune-checkpoint blockade if their tumour cells carry a mutation in the gene PPP2R1A.

Nature, Published online: 08 July 2025; doi:10.1038/d41586-025-02053-4

Women with a rare type of ovarian cancer have prolonged survival after receiving immune-checkpoint blockade if their tumour cells carry a mutation in the gene PPP2R1A.

From Nature via this RSS feed